Skip to content

Insider · CIK 0001630542

Hurvitz Chaim

Reports to the SEC for 2 companies · WILMINGTON, DE

Transactions

15

Companies

2

Filings

7

CIK

0001630542

Forms 4 and 5

Insider transactions

15 trades
DateCompanyValue
2025-04-09NRXPNRX Pharmaceuticals, Inc. · Stock Option (right to buy)A Award—
2024-06-17DRORDror Ortho-Design, Inc. · Stock Option (Right to Buy)A Award+$78.2K
2023-08-30NRXPNRX Pharmaceuticals, Inc.P Purchase+$20.1K
2023-08-14DRORDror Ortho-Design, Inc. · Series A Convertible Preferred StockA Award—
2023-08-14DRORDror Ortho-Design, Inc. · Common WarrantsA Award—
2022-11-18NRXPNRX Pharmaceuticals, Inc.P Purchase+$44.4K
2022-11-18NRXPNRX Pharmaceuticals, Inc.P Purchase+$44.4K
2022-11-17NRXPNRX Pharmaceuticals, Inc.P Purchase+$186K
2022-11-17NRXPNRX Pharmaceuticals, Inc.P Purchase+$186K
2022-11-16NRXPNRX Pharmaceuticals, Inc.P Purchase+$285K
2022-11-16NRXPNRX Pharmaceuticals, Inc.P Purchase+$285K
2022-10-21NRXPNRX Pharmaceuticals, Inc. · Employee Stock OptionA Award—
2021-05-24NRXPNRX Pharmaceuticals, Inc. · Common Stock Warrant (Right to buy)A Award—
2021-05-24NRXPNRX Pharmaceuticals, Inc.A Award—
2021-05-24NRXPNRX Pharmaceuticals, Inc.A Award—

Recent filings

7

Companies

2

Address

C/O NRX PHARMACEUTICALS, INC. 1201 ORANGE AVENUE, SUITE 600

WILMINGTON, DE, 19801